Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2026-01-11 @ 11:23 AM
Study NCT ID:
NCT03091933
Status:
UNKNOWN
Last Update Posted:
2017-12-06
First Post:
2017-03-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)
Sponsor:
Ciusss de L'Est de l'Île de Montréal
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-06
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2017-03-21
First Submit QC Date:
None
Study First Post Date:
2017-03-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-04
Last Update Post Date:
2017-12-06
Last Update Post Date Type:
ACTUAL